Dr Reddy’s launches anti-asthma drug – Hindu Business Line

Dr Reddy's launches anti-asthma drug
Hindu Business Line
The drug is used for treating asthma and seasonal allergies. The move follows the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's Abbreviated New Drug Application for Montelukast Sodium Oral Granules, a company press
Dr Reddy's launches generic anti-asthma drug in US marketMoneycontrol.com
Dr. Reddy's introduces generic Singulair oral granules in the USNews-Medical.net

all 17 news articles »

View full post on asthma – Google News

Dr Reddy’s Laboratories launches generic anti-asthma drug in US market – Economic Times

Dr Reddy's Laboratories launches generic anti-asthma drug in US market
Economic Times
NEW DELHI: Drug maker Dr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US market. The launch was made on September 26 following approval by the United States

and more »

View full post on asthma – Google News

Dr Reddy’s launches asthma drug in US market – NDTV


Business Today

Dr Reddy's launches asthma drug in US market
NDTV
Dr Reddy's Laboratories today said it has launched Montelukast Sodium tablets, used for treating asthma and allergies, in the US market after getting approval from the American health regulator. The company received approval from US Food and Drug
Aurobindo gets USFDA nod for asthma drugMoneycontrol.com
Aurobindo, Glenmark get US nod for asthma drugBusiness Today
Mylan introduces Generic Version of Singulair, Singulair Chewable TabletsRTT News

all 75 news articles »

View full post on asthma – Google News

Dr Reddy’s launches asthma drug in US market – Business Standard


Business Standard

Dr Reddy's launches asthma drug in US market
Business Standard
Dr Reddy's Laboratories today said it has launched Montelukast Sodium tablets, used for treating asthma and allergies, in the US market after getting approval from the American health regulator. The company received approval from US Food and Drug
Aurobindo gets USFDA nod for asthma drugMoneycontrol.com
Aurobindo, Glenmark get US nod for asthma drugBusiness Today
Aurobindo gets US FDA nod for anti-asthma, chewable tabletsHindu Business Line
News-Medical.net –mydigitalfc.com
all 73 news articles »

View full post on asthma – Google News

Dr. Reddy’s Laboratories launches Zafirlukast tablets in US – Trading Markets (press release)

Dr. Reddy's Laboratories launches Zafirlukast tablets in US
Trading Markets (press release)
Laboratories (NYSE: RDY | PowerRating) reported on Saturday the launch of its Zafirlukast tablets (10mg and 20mg) in the US market, for treating asthma.
Dr Reddy's gets USFDA nodIndian Express
Dr. Reddy's launches generic AccolateDrug Store News
Dr Reddy's gets FDA nod to launch Zafirlukast in USSify
Indlaw.com
all 57 news articles »

View full post on asthma – Google News

Dr. Reddy’s launches generic Accolate – Drug Store News

Dr. Reddy's launches generic Accolate
Drug Store News
22) Indian generic drug maker Dr. Reddy's Labs has launched a version of an asthma drug for the US market, the company said. Dr. Reddy's announced the
Dr Reddy's introduces Zafirlukast tablets in USPharmaceutical Business Review
Dr. Reddy's Laboratories launches Zafirlukast tablets in USTrading Markets (press release)
Dr Reddy's gets nod to launch ZafirlukastSify
MarketWatch –Economic Times –India Infoline.com
all 53 news articles »

View full post on asthma – Google News

Dr Reddy’s introduces Zafirlukast tablets in US – Pharmaceutical Business Review

Dr Reddy's introduces Zafirlukast tablets in US
Pharmaceutical Business Review
Accolate, an oral prescription medicine used to treat asthma, works by blocking substances in the body called leukotrienes, which may contribute to the
Dr Reddy's gets nod to launch ZafirlukastSify
Dr. Reddy's launches generic asthma drug in USMarketWatch
Dr Reddy's gets FDA nod to launch anti-asthma tablets in USEconomic Times
India Infoline.com
all 49 news articles »

View full post on asthma – Google News

Dr Reddy’s gets nod to launch Zafirlukast – Sify

Dr Reddy's gets nod to launch Zafirlukast
Sify
Zafirlukast is a prescription medicine used for treating asthma. According to IMS Health, the medicine had total US sales of approximately $50 million for
Dr. Reddy's launches generic asthma drug in USMarketWatch
Dr Reddy's gets FDA nod to launch anti-asthma tablets in USEconomic Times
Dr Reddys Laboratories announces the launch of Zafirlukast tabletsIndia Infoline.com

all 41 news articles »

View full post on asthma – Google News